Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clevudine vs tenofovir vs clevudine + tenofovir in HBeAg-negative chronic hepatitis B
2008-000733-21Phase 2Active
- Sponsor
- ANRS
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Chronic Hepatitis B (CHB) comparing Clevudine monotherapy, Tenofovir disoproxil monotherapy and Clevudine + tenofovir disoproxil (3 arms). Primary endpoints: Primary efficacy endpoint and Primary safety endpoint. Started Jun 2008; status: active.
02
Drugs
clevudinetenofovir disoproxil fumarate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on 2008-000733-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000733-21.